Navigation Links
Beckman Coulter Announces Third Quarter 2008 Results
Date:10/28/2008

communicating between the instruments, automation system and the

laboratory information system.

* Entered into an agreement with Nephromics LLC to buy out future U.S.

royalties for tests for the detection, monitoring and risk

assessment of preeclampsia, a leading cause of maternal death.

* Signed a new agreement with Adventist Health of Northern California

valued at approximately $36 million over six years to be the sole

supplier of Chemistry, Immunoassay and Hematology products to an

integrated health network that includes 18 hospitals, numerous

outpatient facilities and 15 home care agencies.

First Nine Months Summary

For the first nine months of 2008, revenue increased 16.0%, with the acquired flow cytometry products contributing approximately 1% to this growth. Revenue grew 11.9% in constant currency, compared to the first nine months of 2007. Year-to-date recurring revenue was up 12.2%, or 8.0% in constant currency. Year-to-date gross margin, reflecting unusually high levels of cash instrument and international sales, decreased 70 basis points to 46.2%. Adjusted operating margin decreased 30 basis points, while adjusted operating income increased by 12.9% to $240.4 million.

Adjusted operating income growth was achieved while absorbing dilution from: (1) $7.4 million related to the flow cytometry acquisition, (2) $3.6 million for changes in retirement vesting terms for new share-based compensation and (3) a payment of $4.6 million related to currency swap agreements embedded in the company's facility leases.

On an adjusted basis, net earnings increased 9.2%, and on a fully diluted share basis, earnings per share increased 8.4% over the same period 2007. Adjusted net earnings were negatively impacted by a 130 basis point increase in the adjusted tax rate, from 25.6% to 26.9%, as a result of fewer favorable discrete items in 2008. '/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
2. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
3. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
4. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
5. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
6. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
7. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
8. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
9. Align Technology Announces Third Quarter Fiscal 2008 Results
10. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
11. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... (PRWEB) September 16, 2014 The rapidly ... concern for health plans, employers and PBMs as spending ... of their drug lists. Once a concentrated, patient-specific practice, ... 25 webinar from Atlantic Information Services, Inc. (AIS), ... will offer details of what one leading health ...
(Date:9/16/2014)... The Living Ethics lecture series returns ... on what it means to live in an ethically ... and thought-provoking topics. , “The Museum’s job is to ... at their world differently. The Living Ethics series’ ... truly enlightening dialogue,” says Richard Conti, Chief Wonder Officer, ...
(Date:9/16/2014)... Botanica Day Spa ... kicking off September with fall-themed discounts and giveaways. ... chose to highlight lumablanc® which contains Pevonia’s exclusive ... with the skin. , Lumablanc® was recently released ... anti-aging line. The brightening formula, containing a blend ...
(Date:9/16/2014)... Reading, MA (PRWEB) September 16, 2014 ... announce its partnership with Fairfax Egg Bank. The collaboration ... and expand the donor egg offering at the Fertility ... operated since 2006 and offers the nation’s largest selection ... is advantageous for several reasons:, , ...
(Date:9/15/2014)... 2014 With the variety of drugs ... to know the details on each one. However, it ... substances falling into their teen’s hands. , Synthetic ... among high school students. With varied, misleading and potentially ... it can be difficult for parents to separate the ...
Breaking Medicine News(10 mins):Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3
... today that the United States Food and,Drug Administration ... first LDL cholesterol lowering medication also indicated for,improving ... mellitus (DM) in,combination with metformin, sulfonylureas, or insulin, ... with other anti-diabetic agents., The ADA estimates ...
... by New York City Mayor,Michael Bloomberg, Lance Armstrong ... discussed Lance,s request to the Surgeons General,Collective to ... "This year alone, 1.4 million Americans are expected ... lose their lives to the disease," said,Lance Armstrong, ...
... Diego Supercomputer Center and other parts of the University ... Disease, fusion energy and climate change - were awarded ... as part of its 2008 Innovative and Novel Computational ... total, the DOEs Office of Science awarded a record ...
... seeds, chemo wafers slowed disease, boosted survival , , ... radioactive seeds and chemotherapy wafers following surgery shows ... study finds. , The early-phase clinical trial, led ... University of Cincinnati and University Hospital, included 34 ...
... Postings Part of Available Resources-, JACKSONVILLE, Fla., ... this group of returning wounded veterans are the ... Project has expanded,their ever-evolving battery of programs and ... (WtoW) initiative., The Warriors to Work (WtoW) ...
... this morning that Chairman and CEO Fred Hassan,intends ... million of Schering-Plough,Common Shares with personal funds., ... I purchased $4.68 million in,Schering-Plough Common Shares at ... this investment in Schering-Plough reflects my long-term,confidence in ...
Cached Medicine News:Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:DOE awards supercomputing time to UCSD, SDSC researchers 2Health News:DOE awards supercomputing time to UCSD, SDSC researchers 3Health News:Combo Therapy Shows Promise in Treating Brain Tumors 2Health News:Wounded Warrior Project (WWP) Expands Service Offerings for Injured Soldiers with the New 'Warriors to Work' Program 2Health News:Schering-Plough CEO to Buy $2 Million in Common Shares 2Health News:Schering-Plough CEO to Buy $2 Million in Common Shares 3
(Date:9/15/2014)... Chek Diagnostics, the U.S.-based manufacturer of both ... diagnostic products, has again been named to the ... in America. The Inc. 5000 ranking is ... Diagnostics earned its place on the list by growing ... For Chek Diagnostics, who appears on the ...
(Date:9/15/2014)... Pa. , Sept. 15, 2014  Inovio Pharmaceuticals, ... it has met the stringent listing criteria for the ... to this U.S. stock exchange from the NYSE MKT. ... ticker symbol, "INO." NASDAQ Global Select ... the highest initial listing standards of any exchange in ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 ... the "Digital Pathology Market by Slide Scanners, Analytics, ... Global Forecasts & Trends to 2018" report to ... the global digital pathology market into different products and ... digital pathology products market, followed by analytics. The analytics ...
Breaking Medicine Technology:Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 2Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 3
... (NASDAQ: GPRO ) announced today that the Company ... Growth Stock Conference in Chicago on June 15, 2011 at ... presentation is scheduled to be webcast live and may be ... website at www.gen-probe.com . The webcast will be available ...
... Educating the critical players in the pharmaceutical marketplace ... been considered a key component of a successful product ... diminished, education efforts have taken on new importance among ... Facing a competitive environment, organizations with new products are ...
Cached Medicine Technology:Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference 2Educating Key Stakeholders to Support a Successful Pharmaceutical Product Launch 2
... Laboratories Platelia Aspergillus EIA is a one-stage ... monoclonal antibody EBA-2 to detect circulating galactomannan ... 3 hours. , ,When used in conjunction ... is an aid in the diagnosis of ...
... The GreenLight PV Laser System ... the Prostate) Procedure for the ... (BPH) allows the urologist to ... a TURP with the safety ...
... diagnosis is generally confirmed by a positive heterophil ... however, is not indicated by the heterophil antibody ... - 20 percent of children. Detection and ... fully ascertain the stage of EBV infection. ...
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
Medicine Products: